Pacira BioSciences (PCRX) Intangibles (2010 - 2026)

Pacira BioSciences' Intangibles history runs 14 years deep, the most recent figure standing at $353.2 million for Q1 2026.

• In Q1 2026, Intangibles fell 18.79% year-over-year to $353.2 million; the TTM figure through Mar 2026 stood at $353.2 million (down 18.79% YoY), while the FY2025 annual figure was $368.1 million, down 13.59% from the prior year.
• Intangibles was $353.2 million for Q1 2026 at Pacira BioSciences, down from $368.1 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $609.6 million in Q1 2022 to a low of $353.2 million in Q1 2026.
• Historically, Intangibles has averaged $476.3 million across 5 years, with a median of $468.9 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Intangibles jumped 544.76% in 2022, then retreated 18.79% in 2026.
• A 5-year view of Intangibles shows it stood at $540.5 million in 2022, then slipped by 10.6% to $483.3 million in 2023, then declined by 11.85% to $426.0 million in 2024, then dropped by 13.59% to $368.1 million in 2025, then declined by 4.04% to $353.2 million in 2026.
• The last three Intangibles figures came in at $353.2 million (Q1 2026), $368.1 million (Q4 2025), and $382.4 million (Q3 2025), per Business Quant data.